Constantine John Kardaras's most recent trade in Imunon Inc was a trade of 1,750 Option to Purchase Celsion Common Stock done . Disclosure was reported to the exchange on June 13, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Inc | Constantine John Kardaras | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 1,750 | 5,833 | - | - | Option to Purchase Celsion Common Stock | |
| Imunon Inc | Constantine John Kardaras | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 1,750 | 4,083 | - | - | Option to Purchase Celsion Common Stock | |
| Imunon Inc | Constantine John Kardaras | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 35,000 | 35,000 | - | - | Option to Purchase Celsion Corporation Common Stock | |
| Imunon Inc | Constantine John Kardaras | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 10,000 | 10,000 (0%) | 0% | 0 | Celsion Corporation Common Stock |